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CHILDHOOD chronic myelogenous leuk-
aemia (CML) is rare. Iversen (1966)
found only 7 cases among 516 leukaemic
children, and Reisman and Trujillo (1963)
found 7 in 160 patients under 10 years
of age. The Ph' chromosome is not
always found (Reisman and Trujillo,
1963; Hardisty, Speed and Till, 1964;
Tijo et al., 1966; and Holton and Johnson,
1968), and it seems reasonable to suppose
that Ph1 negative CML is relatively more
common in children than in adults. Here
we report a case of childhood CML
which, as far as we can ascertain, is
the earliest onset of Ph1-positive CML
recorded, and which has several unusual
features.
L.C. is the first child of young healthy
non-consanguinous parents. He was born
in May 1974 after an uneventful preg-
nancy. His mother had no infections
during pregnancy and had no drugs
other than oral iron. No diagnostic
x-rays were administered during the
pregnancy and no other potentially car-
cinogenic hazards are known to have
been encountered. At the age of 11
months he developed diarrhoeaand vomit-
ing and on examination at that time
was found to be a healthy well-grown
child with a mild hydrocephalus (H.C.
52 cm). Abnormalities were otherwise
confined to the abdomen and he was
found to have an enormously enlarged
firm spleen which extended 15 cm below
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the costal margin and 5 cm across the
midline. The liver was 2 cm below the
costal margin. Haematological investiga-
tion revealed a Hb concentration of
6.4 g/dl, WBC 539 X 106/ml (polymorphs
20%, monocytes. 4o, eosinophils 14%
lymphocytes 1%, blasts 5%, promyelo-
cytes 9%. myelocytes 20%, metamyelo-
cytes 17%) and platelets 95 x 106/ml.
Theperipheralbloodpicturewascompatible
with chronic myelogenous leukaemia.
The bone marrow showed increased
cellularity with reduced megakaryocytes;
erythroid series 30o promyelocytes 40,
myelocytes 15%, metamyelocytes 20%,
neutrophils 23%, lymphocytes 110%,
basophils 5Qo, eosinophils 16%, reticulin
cells 1% and unspecified blasts 2%.
Other investigations were: leucocyte
alkaline phosphatase score 10 (control
30), electrophoresis showed wellmarked
a, and /82 globulin, serum immunoglo-
bulins were normal except for a slight
increase in IgM only.
Treatment was started on 27 June
1975 with busulphan, 1 mg/day. The
dose was calculated on the basis of this
child's surface area but nevertheless was
high in comparison with the usual dose
in adult patients. Allopurinol, 50 mg/
day, was also given. Response to therapy
in terms of reduction in spleen size and
fall in WBC has been slow, but the
child's well-being remains good to date.
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performed on peripheral blood samples
taken on 25 June 1975 (WBC 552 x 106/
ml; lymphocytes 500, blasts 3%O); on
4 July 1975 (WBC 473 x 106/ml; lympho-
cytes 4%, blasts 0o); and on 9 October
1975 (WBC 89 x 106/ml; lymphocytes
80%, blasts 00%). On these dates the
remaining white blood cells consisted of
maturing myeloid elements.
Bone marrow and peripheral blood
cells from the patient were found to be
46XY Ph'+, typical of CML. The Ph'
chromosome was identified by the G-
banding technique as the conventional
translocation 22q- : 9q-+. In order to
rule out alternative explanations of the
abnormality, blood samples from the
parents were also studied. Both the
father (46XY) and the mother (46XX)
had normal chromosome complements.
An unusual finding in L.C. was the
persistence of Ph'+ cells in division
following culture of the peripheral blood
cells for 5 days in the absence of phyto-
haemagglutinin. Whether such persis-
tence of division in the leukaemic cells
is associated with this juvenile incidence
of the disease is not known, but in adult
chronic phase CML the leukaemic cells
normally cease dividing at about 80 h in
culture. In cultures of PHA-stimulated
peripheral blood cells of L.C., 60-70%
of the mitoses scored between 48 and
96 h in culture were Ph1-, indicating
that, as in adult CML, the T-lympho-
cytes do not carry the chromosomal
abnormality.
The clinical characteristics of the
disease and the presence of the Ph1
chromosome are as reported in adult
CML. The myeloid characteristics of the
leukaemic cells were further investigated
by assaying for the presence ofgranulocyte
precursor cells (CFU,) (Bradley and Met-
calf, 1966; Pluznik and Sachs, 1966).
Peripheral blood cells of the patient were
cultured on a feeder layer of normal
human peripheral white blood cells, using
the technique reported by Pike and
Robinson (1970) both before (25 June
1975) and after (4 July and 4 October
1975) chemotherapy. As controls, the
blood cells from the mother and father
and a number of other normal adults
were cultured. In all cases both colonies
(containing more than 50 cells by 10 days
of culture) and clusters (containing be-
tween 2 and 50 cells) were scored. Also,
for comparison, data from 14 normal
children (Ragab et al., 1974) are given in
the Table.
In patient L.C. the concentration
of CFUC in the peripheral blood was
greatly in excess of normal values when
initially assayed. During the course of
chemotherapy however, a gradual decline
was seen. The initial high CFUC numbers
and the subsequent response to chemo-
TABLE
Donor
LC 25 June 1975
LC 4 July 1975
LC 9 October 1975
Normal childrenb
Normal child
Mother of LC
Father of LC
Normal adults
Peripheral blood
CFU,/106 cells
_
Colonies Clusters
6630 1540
1400 300
57 30
18 No data
No data No data
1 4
0 2
1-7 20
(0_5) (4-41)
Peripheral blood
terminal transferase
units/108 cellsa
Not tested
4 0
2-9
No data
<0 05
<0 05
Not tested
<0 002C
Bone marrow and/or
peripheral blood
chromosomes
46XY Ph'
46XY Ph'+
46XY Ph'+
46XX
46XY
a Terminal deoxynucleotidyl transferase was isolated and assayed according to the method of McCaffrey
et al., 1975. 1 unit is the amount of enzyme that will catalyse the incorporation of 1 nmol deoxyguanosine
5'-triphosphate into acid insoluble material in 1 h in the standard assay.
b From Ragab et al., 1974.
c From McCaffrey et al., 1975.
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therapy follows a pattern similar to that
reported in adult CML (Moore, Williams
and Metcalf, 1973; Goldman, Th'ng and
Lowenthal, 1974). The CFUC concentra-
tion in the peripheral blood of both
parents and other normal adults was
uniformly low. Normal children give
apparently somewhat higher levels of
CFUC than do adults (Ragab et al., 1974).
Terminal deoxynucleotidyl transferase
was found at a level of 4OOU/108 cells
in a sample of the patient's blood taken
on 4 July 1975, shortly after the com-
mencement of chemotherapy. This find-
ing was unexpected, since terminal de-
oxynucleotidyl transferase is believed to
be an enzyme specific for thymic or
pre-thymic cells and is also present in
cells of leukaemias with a T-cell com-
ponent (McCaffrey, Smoler and Baltimore,
1973; Coleman et al., 1974; Sarin and
Gallo, 1974; and McCaffrey et al., 1975). It
is absent in peripheral blood lymphocytes
of normal people (McCaffrey et al., 1975).
The presence of the enzyme in the
peripheral blood of L.C. was confirmed
in a second sample taken on 9 October
1975, when the level was 2-9 u/108 cells.
These values are similar to those
reported for thymocytes (Coleman et al.,
1974) and ALL cells (Sarin and Gallo,
1974; McCaffrey et al., 1975). The en-
zyme was identified by its chromato-
graphic properties which were similar
to those reported by other workers (Sarin
and Gallo, 1974; and McCaffrey, et al.,
1975) and its ability to polymerize deoxy-
guanosine 5'-triphosphate on an oligo
(dpA)1218 initiator, thus distinguishing it
from a " similar " enzyme reported to
be present in murine myeloma (Penit,
Paraf and Chapeville, 1975). On phos-
phocellulose chromatography a second,
early eluting, peak ofterminal transferase
activity (representing ca 8% of the total
activity was observed. Similar early-
eluting peaks of activity have been ob-
served from both human and murine
thymocytes (Kung et al., 1975) and in
other terminal transferase-positive leuk-
aemias (McCaffrey et al., 1975).
The peripheral blood from an age-
matched haematologically normal child,
along with the blood from the mother
were also examined for terminal trans-
ferase activity. No activity was detected
in either of these samples down to a
level of ca 0 05 U/108 cells. Previous re-
ports have shown terminal transferase
to be absent from the peripheral blood
of normal adults down to a level of
0-002 u/108 cells (McCaffrey et al., 1975).
Due to the difficulty ofobtaining sufficient
material from normal infants we cannot
exclude the possibility that terminal
transferase is present in young children
at levels below 0 05 U/108 cells.
If, as is generally believed, terminal
transferase is specific for thymic or
prethymic cells, its presence in the
present case is unexpected. Previous
studies of CML have shown that terminal
transferase is not present at detectable
levels in the chronic phase of the disease
(McCaffrey et al., 1975) but appeared
at levels comparable with those found in
thymocytes and ALL cells in certain
cases ofCML (1 in 4) which had undergone
blast transformation. The appearance of
terminal transferase in such cases may
be compatible with, and related to, the
observation that for 10-15% of CML
patients in blast transformation the re-
sulting leukaemic cells seem to have some
" lymphoid " characteristics (Boggs, 1974).
If indeed the enzyme is specific for
thymic and pre-thymic cells, as suggested
by several authors (Coleman et al., 1974;
McCaffrey et al., 1975), the presence of
terminal transferase in some blastic CMLs
may represent a true " lymphoblastoid "
transformation. In L.C., at the time
of examination, however, the peripheral
blood and bone marrow showed a pre-
dominance of maturing myeloid elements
and no evidence for blastic crisis. It
seems unlikely that the higher levels
of terminal transferase found in the
samples were derived from the relatively
low numbers of lymphocytes present
(see case report) since the enzyme is
absent from normal peripheral blood
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lymphocytes and, if it were derived
solely from the lymphocytes in L.C.
the levels would have to be at least
10 times those reported for ALL cells.
The same argument can be applied to
the monocytes. During chemotherapy
the relative numbers of granulocyte pre-
cursor cells (CFUC) fell appreciably. In
contrast there was no change in the
level ofthe terminal transferase, indicating
that in this case chemotherapy is not
selectively removing the terminal trans-
ferase-positive cells from the peripheral
blood, and further, that the CFUC, as
the lymphocytes and monocytes, were
not likely to have been the source of the
enzyme. This implies that, in this case,
the enzyme originated in the maturing
myeloid cells.
Other authors (Trujillo and Ohno,
1963) have argued that a pluripotent
" stem " cell is involved in CML, since
the Ph' chromosome has been demon-
strated in both erythroid and granulocytic
cells although it is absent in lymphocytes.
The finding that a proportion of cases in
blast transformation, and in patient L.C.
in the chronic phase, show terminal
transferase activity (a lymphoid charac-
teristic?) may indicate a " reversion "
of cells to earlier (embryonic) charac-
teristics, a phenomenon not unknown
in malignant cells. Alternatively, the
enzyme may not be restricted to pre-T
cells and thymocytes but may be present
in many types of cells (albeit at low
levels) and a marked enhancement in
the levels of the enzyme occurs in certain
disease states.
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